NGF and Alzheimer disease: There has been studies utilizing the IND of mutated human NGF (R100) in an AD animal model (Capsoni et al., 2011, 2012), where the mutated human NGF retained the potential of NGF’s neurotrophic effect without eliciting the pain-related response.